Latest research report on “Artificial Pancreas Devices Systems Market” now available at high quality database of ReportsnReports.com with market size, share, trends, competitive and statistical analysis. An exclusive data offered in this report is collected by research and industry experts team.
Get Free Sample Copy @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=5558533
The Artificial Pancreas Device System is a system of devices that closely mimics the glucose regulating function of a healthy pancreas.
Most Artificial Pancreas Device Systems consists of three types of devices already familiar to many people with diabetes: a continuous glucose monitoring system (CGM) and an insulin infusion pump. A blood glucose device (such as a glucose meter) is used to calibrate the CGM.
A computer-controlled algorithm connects the CGM and insulin infusion pump to allow continuous communication between the two devices. Sometimes an artificial pancreas device system is referred to as a “closed-loop” system, an “automated insulin delivery” system, or an “autonomous system for glycemic control.”
An Artificial Pancreas Device System will not only monitors glucose levels in the body but also automatically adjusts the delivery of insulin to reduce high blood glucose levels (hyperglycemia) and minimize the incidence of low blood glucose (hypoglycemia) with little or no input from the patient.
This report contains market size and forecasts of Artificial Pancreas Devices Systems in global, including the following market information:
Global Artificial Pancreas Devices Systems Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Artificial Pancreas Devices Systems Market Sales, 2017-2022, 2023-2028, (Units)
Global top five Artificial Pancreas Devices Systems companies in 2021 (%)
The global Artificial Pancreas Devices Systems market was valued at 92 million in 2021 and is projected to reach US$ 197.2 million by 2028, at a CAGR of 11.6% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Threshold Suspended Device Systems Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Artificial Pancreas Devices Systems include Medtronic, Bigfoot Biomedical, Beta Bionics, Admetsys, Insulet, Tandem Diabetes Care and Defymed, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Artificial Pancreas Devices Systems manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Artificial Pancreas Devices Systems Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Units)
Global Artificial Pancreas Devices Systems Market Segment Percentages, by Type, 2021 (%)
– Threshold Suspended Device Systems
– Hybrid Closed-loop APDS
– Other Systems
Global Artificial Pancreas Devices Systems Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Units)
Global Artificial Pancreas Devices Systems Market Segment Percentages, by Application, 2021 (%)
Global Artificial Pancreas Devices Systems Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Units)
Global Artificial Pancreas Devices Systems Market Segment Percentages, By Region and Country, 2021 (%)
– North America
– – US
– – Canada
– – Mexico
– – Germany
– – France
– – U.K.
– – Italy
– – Russia
– – Nordic Countries
– – Benelux
– – Rest of Europe
– – China
– – Japan
– – South Korea
– – Southeast Asia
– – India
– – Rest of Asia
– South America
– – Brazil
– – Argentina
– – Rest of South America
– Middle East & Africa
– – Turkey
– – Israel
– – Saudi Arabia
– – UAE
– – Rest of Middle East & Africa
The report also provides analysis of leading market participants including:
Key companies Artificial Pancreas Devices Systems revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Artificial Pancreas Devices Systems revenues share in global market, 2021 (%)
Key companies Artificial Pancreas Devices Systems sales in global market, 2017-2022 (Estimated), (Units)
Key companies Artificial Pancreas Devices Systems sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
– Bigfoot Biomedical
– Beta Bionics
– Tandem Diabetes Care
More information about Discount offers (25% or More) @ https://www.reportsnreports.com/contacts/discount.aspx?name=5558533
About Us: ReportsnReports.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets.
We provide 24/7 online and offline support to our customers.
E-mail: [email protected]
Phone: +1 888 391 5441